Edmond Lay


I’m inspired by our innovative clients and grateful for the chance to support them as they reach their next great success.


Edmond’s practice focuses on corporate and securities matters, including corporate governance and compliance, mergers and acquisitions, venture capital financings and public offerings. He has broad experience representing public and private life science and technology companies in a wide range of sectors, including biotechnology, medical device and pharmaceutical through all stages of development from formation to exit. In addition, Edmond works with numerous venture capital firms in connection with their investments in emerging growth companies.

Download full bio 


  • Flexion Therapeutics Agrees to Sell to Pacira BioSciences 

  • Shoreline Biosciences Enters Collaboration With BeiGene to Develop Genetically Modified Cell Therapies 

  • Horizon Therapeutics to Acquire Viela Bio 

  • Poseida Therapeutics – $224 Million IPO 

  • Satsuma Pharmaceuticals – $83 Million IPO  

  • View all


    The great outdoors, LA Lakers, board games and craft breweries


  • Northwestern University School of Law
    JD, 2015

  • University of California, Los Angeles
    BA, Political Science

Admissions & Credentials



  • American Bar Association

  • San Diego County Bar Association

  • National Asian Pacific American Bar Association